Anticipated growth for Q4 was weakened by a resurgence of COVID-19 and was not enough to sustain growth with FY20 ending at -3.3% YoY decline.
For FY20, according SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access (VA) Adjunct Products market was down -3.3% YoY, while Q420 revenue was up +1.2% YoY.
The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.
Among the many topics covered in the comprehensive Q420/FY20 Infection Prevention: US Vascular Access Adjunct Market* are:
- Complete Market Overview
- Companies' Revenues and Market Share
- Dressings: Securement and Stabilization of VA Devices
- Antimicrobial Devices
- Antimicrobial IV Skin Preps
- Mechanical Securement Devices
- Q420 News and Highlights
In 2020, the COVID-19 crisis put the spotlight on infection control within hospitals and further reinforces the importance of the infection preventionist (IP) in the “new normal” healthcare setting. Non-compliance with INS SOP and modifications of hospital procedures during the peak of the COVID-19 crises is expected to increase CRBSIs. Numerous modifications taking place during COVID-19 such as ...
